1. |
Anderson NE, Chung K, Willoughby E, et al. Neurological manifestations of phaeochromocytomas and secretory paragangliomas:a reappraisal[J]. J Neurol Neurosurg Psychiatry, 2013, 84(4):452-457.
|
2. |
Plouin PF, Duclos JM, Soppelsa F, et al. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma:analysis of 165 operations at a single center[J]. J Clin Endocrinol Metab, 2001, 86(4):1480-1486.
|
3. |
Chen H, Sippel RS, O'dorisio MS, et al. The North American neuroendocrine tumor society consensus guideline for the diagnosis and management of neuroendocrine tumors[J]. Pancreas, 2010, 39(6):775-783.
|
4. |
Prys-Roberts C. Phaeochromocytoma-recent progress in its management[J]. Br J Anaesth, 2000, 85(1):44-57.
|
5. |
Adler JT, Meyer-Rochow GY, Chen H, et al. Pheochromocytoma:current approaches and future directions[J]. Oncologist, 2008, 13(7):779-793.
|
6. |
Bruynzeel H, Feelders RA, Groenland TH, et al. Risk factors for hemodynamic instability during surgery for pheochromocytoma[J]. J Clin Endocrinol Metab, 2010, 95(2):678-685.
|